SCHEMBL4908110

SCHEMBL4908110

CC(=O)C(C)CC(=O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
SLC15A1 P46059 2/20 0.55
CDC25B P30305 1/20 0.50
MMP9 P14780 1/20 0.48
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CA12 O43570 1/20 0.46
ABCB1 P08183 1/20 0.45
TSHR P16473 1/20 0.45
ELANE P08246 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ABCC3 O15438 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9636201 0.88 ALDH1A1 (0.58) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL4896293 0.88 SLC15A1 (0.59) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL4900863 0.88 SLC15A1 (0.59) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL12369646 0.88 SLC15A1 (0.59) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL14194794 0.87 SLC15A1 (0.58) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL12282025 0.85 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL18300829 0.85 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL16379300 0.85 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL1195221 0.85 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B
SCHEMBL111390 0.84 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1SLC15A1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 632 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630491-B2 Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from secondary alcohols and 2,2,4,4-tetramethylcyclobutanedione using homogeneous catalysts EASTMAN CHEMICAL COMPANY (US) 2026-05-19 US claimed
EP-4255881-B1 PRODUCTION OF 2,2,4, 4-TETRAMETHYLCYCLOBUTANE-1, 3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS EASTMAN CHEM CO (US) 2024-12-18 EP claimed
US-12129332-B2 Self-supporting photochromic polyurethane film, method of manufacturing the film, article comprising said film NANOGATE SE (DE) 2024-10-29 US claimed
EP-4320254-A1 SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE Symrise AG (DE) 2024-02-14 EP claimed
US-20230406792-A1 PRODUCTION OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2023-12-21 US claimed
EP-4255881-A1 PRODUCTION OF 2,2,4, 4-TETRAMETHYLCYCLOBUTANE-1, 3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS Eastman Chemical Company (US) 2023-10-11 EP claimed
WO-2022214180-A1 SUSTAINABLE PROCESS FOR THE PREPARATION OF 5-METHYLHEPT-2-EN-4-ONE SYMRISE AG (DE) 2022-10-13 WO claimed
WO-2022164313-A1 METHOD FOR COATING A POLYMER SURFACE COMPRISING KETONE-TREATMENT OF THE POLYMER SURFACE NANOGATE EUROGARD SYSTEMS B.V. (NL) 2022-08-04 WO claimed
WO-2022119793-A1 PRODUCTION OF 2,2,4, 4-TETRAMETHYLCYCLOBUTANE-1, 3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2022-06-09 WO claimed
US-11091582-B2 Urethane-modified prepolymers containing pendent alkyl groups, compositions and uses thereof PRC-DESOTO INTERNATIONAL, INC. (US) 2021-08-17 US claimed
US-20210040280-A1 SELF-SUPPORTING PHOTOCHROMIC POLYURETHANE FILM, METHOD OF MANUFACTURING THE FILM, ARTICLE COMPRISING SAID FILM NANOGATE SE (DE) 2021-02-11 US claimed
EP-3517573-B1 SELF-SUPPORTING PHOTOCHROMIC THERMOPLASTIC-POLYURETHANE FILM WITH IMBIBED KETONE NANOGATE SE (DE) 2020-02-12 EP claimed
WO-2019145388-A1 SELF-SUPPORTING PHOTOCHROMIC POLYURETHANE FILM, METHOD OF MANUFACTURING THE FILM, ARTICLE COMPRISING SAID FILM NANOGATE SE (DE) 2019-08-01 WO claimed
WO-2019145391-A1 PHOTOCHROMIC OPTICALLY TRANSPARENT ELECTRICALLY CONDUCTIVE FILM LAMINATE NANOGATE SE (DE) 2019-08-01 WO claimed
WO-2019145387-A1 POLYCARBONATE LAMINATE WITH PHOTOCHROMIC THERMOPLASTIC FILM NANOGATE SE (DE) 2019-08-01 WO claimed
EP-3517573-A1 SELF-SUPPORTING PHOTOCHROMIC THERMOPLASTIC-POLYURETHANE FILM WITH IMBIBED KETONE Nanogate SE (DE) 2019-07-31 EP claimed
US-20180112025-A1 URETHANE-MODIFIED PREPOLYMERS CONTAINING PENDENT ALKYL GROUPS, COMPOSITIONS AND USES THEREOF PRC-DESOTO INTERNATIONAL, INC. 2018-04-26 US claimed
US-12630491-B2 Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from secondary alcohols and 2,2,4,4-tetramethylcyclobutanedione using homogeneous catalysts EASTMAN CHEMICAL COMPANY (US) 2026-05-19 US disclosed
EP-0013617-B1 PENICILLIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING CERTAIN OF THESE COMPOUNDS BEECHAM GROUP PLC (GB) 1984-07-04 EP disclosed
US-4336024-A USING ORGANIC SOLVENTS AIRWICK INDUSTRIES, INC. (US) 1982-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180112025-A1 URETHANE-MODIFIED PREPOLYMERS CONTAINING PENDENT ALKYL GROUPS, COMPOSITIONS AND USES THEREOF ESD, XRCC5, PAG1 ALDH1A1 1165/4885MAPK1 3808/4885L3MBTL1 2759/4885
US-11091582-B2 Urethane-modified prepolymers containing pendent alkyl groups, compositions and uses thereof ESD, XRCC5, PAG1 ALDH1A1 1165/4885MAPK1 3808/4885L3MBTL1 2759/4885
US-12630491-B2 Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from secondary alcohols and 2,2,4,4-tetramethylcyclobutanedione using homogeneous catalysts ADH1C, ADH1A, ADH5 ALDH1A1 195/4885MAPK1 1847/4885L3MBTL1 3687/4885
US-20230406792-A1 PRODUCTION OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS ADH1C, ADH1A, ADH5 ALDH1A1 56/4885MAPK1 2680/4885L3MBTL1 3315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.